Literature DB >> 2017973

Factors associated with atrial fibrillation in Q wave anterior myocardial infarction.

T Sugiura1, T Iwasaka, N Takahashi, F Yuasa, M Takeuchi, T Hasegawa, M Matsutani, M Inada.   

Abstract

To elucidate the role of inflammatory and hemodynamic factors in the genesis of atrial fibrillation in acute myocardial infarction, 228 patients with a first Q wave anterior myocardial infarction were studied. Forty-nine patients had pericarditis (detection of pericardial rub by careful auscultation), and 36 patients had echocardiographically demonstrated hydropericardium (presence of pericardial effusion without pericardial rub). During the first 3 days after admission, transient episodes of atrial fibrillation were observed in 10 patients (20%) with pericarditis (group 1), 15 patients (42%) with hydropericardium (group 2), and 20 patients (14%) without pericarditis and hydropericardium (group 3). Although there was no significant difference in the incidence of atrial fibrillation between groups 1 and 3, patients in group 2 had a significantly higher incidence of atrial fibrillation than those in groups 1 and 3. Pulmonary capillary wedge pressure and the number of advanced asynergic segments were found to be the important factors discriminating the three groups by multivariate analysis. Therefore atrial fibrillation after acute Q wave anterior infarction was not related to the inflammatory infiltration involving the atria but to the increase in atrial pressure resulting from hemodynamic change caused by more extensive myocardial damage.

Entities:  

Mesh:

Year:  1991        PMID: 2017973     DOI: 10.1016/0002-8703(91)90146-9

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  7 in total

Review 1.  Atrial Fibrillation Complicating Acute Coronary Syndromes.

Authors:  Sean D Pokorney; Meena Rao; Kent R Nilsson; Jonathan P Piccini
Journal:  J Atr Fibrillation       Date:  2012-10-06

2.  High concentrations of omega-3 fatty acids are associated with the development of atrial fibrillation in the Japanese population.

Authors:  Takeshi Tomita; Takeki Hata; Takahiro Takeuchi; Yasutaka Oguchi; Ayako Okada; Kazunori Aizawa; Megumi Koshikawa; Kyuhachi Otagiri; Hirohiko Motoki; Hiroki Kasai; Atsushi Izawa; Jun Koyama; Minoru Hongo; Uichi Ikeda
Journal:  Heart Vessels       Date:  2012-06-14       Impact factor: 2.037

3.  Association of stage of left ventricular diastolic dysfunction with P wave dispersion and occurrence of atrial fibrillation after first acute anterior myocardial infarction.

Authors:  Remzi Yilmaz; Recep Demirbag; Ismet Durmus; Hasan Kasap; Merih Baykan; Mehmet Kucukosmanoglu; Sukru Celik; Cevdet Erdol
Journal:  Ann Noninvasive Electrocardiol       Date:  2004-10       Impact factor: 1.468

4.  Predictive value of P-wave signal-averaged electrocardiogram for atrial fibrillation in acute myocardial infarction.

Authors:  Dilek Ciçek; Ahmet Camsari; Hasan Pekdemir; Ahmet Kiykim; Necdet Akkuş; Kerem Sezer; Erdem Diker
Journal:  Ann Noninvasive Electrocardiol       Date:  2003-07       Impact factor: 1.468

5.  Incidence and prognostic significance of atrial fibrillation in acute myocardial infarction: the GISSI-3 data.

Authors:  F Pizzetti; F M Turazza; M G Franzosi; S Barlera; A Ledda; A P Maggioni; L Santoro; G Tognoni
Journal:  Heart       Date:  2001-11       Impact factor: 5.994

6.  Effects of right coronary artery PTCA on variables of P-wave signal averaged electrocardiogram.

Authors:  Marco Budeus; Marcus Hennersdorf; Stefan Dierkes; Michael Preik; Matthias P Heintzen; Malte Kelm; Christian Perings
Journal:  Ann Noninvasive Electrocardiol       Date:  2003-04       Impact factor: 1.468

7.  Prognostic Effect of Restoring Sinus Rhythm in Patients with New-Onset Atrial Fibrillation during Acute Coronary Syndrome.

Authors:  Kuan-Jen Su; Wen-Yu Lin; Wei-Shiang Lin; Chin-Sheng Lin; Cheng-Chung Cheng; Jun-Ting Liou; Chen-Hsuan Ho; Shih-Ping Yang; Shu-Meng Cheng; Yuan Hung
Journal:  Acta Cardiol Sin       Date:  2021-03       Impact factor: 2.672

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.